Homologous Recombination Deficiency (HRD) and BRCA 1/2 Gene Mutation for Predicting the Effect of Platinum-Based Neoadjuvant Chemotherapy of Early-Stage Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis

Background: Platinum-based agents may benefit patients with triple-negative breast cancer (TNBC) whose tumors are dysfunctional in DNA repair mechanisms associated with the homologous recombination repair (HRR) genes. The purpose of this meta-analysis was to assess the values of BRCA1/2 and homologo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Yue, Chen, Yujie, Zhang, Di, Wei, Yuce, Li, Zhijun, Li, Qiao, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876589/
https://www.ncbi.nlm.nih.gov/pubmed/35207810
http://dx.doi.org/10.3390/jpm12020323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876589/
https://www.ncbi.nlm.nih.gov/pubmed/35207810
http://dx.doi.org/10.3390/jpm12020323

Ejemplares similares